"Piracetam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A compound suggested to be both a nootropic and a neuroprotective agent.
Descriptor ID |
D010889
|
MeSH Number(s) |
D02.065.064.650 D02.241.081.018.110.650 D03.383.773.812.555
|
Concept/Terms |
Piracetam- Piracetam
- Pyracetam
- Pirazetam
- 2-Pyrrolidone-N-Acetamide
- Pyramem
Sinapsan- Sinapsan
- Piracetam-RPh
- Piracetam RPh
|
Below are MeSH descriptors whose meaning is more general than "Piracetam".
Below are MeSH descriptors whose meaning is more specific than "Piracetam".
This graph shows the total number of publications written about "Piracetam" by people in this website by year, and whether "Piracetam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 3 | 0 | 3 |
2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Piracetam" by people in Profiles.
-
Levetiracetam use during pregnancy in women with epilepsy: Preliminary observations from a tertiary care center in Northern India. Indian J Pharmacol. 2018 Jan-Feb; 50(1):39-43.
-
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study. Eur J Neurol. 2017 10; 24(10):1283-1289.
-
Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network. Epilepsia. 2017 08; 58(8):e101-e106.
-
Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Epilepsy Behav. 2017 08; 73:83-89.